Drug Database
IV

IVIG (Privigen / IVIG, liquid, CSL / IgPro10)

✓ Approved

CSL Behring · 多克隆抗体 · 多克隆抗体

什么是 IVIG?

IVIG 是一种多克隆抗体,由CSL Behring研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

商品名Privigen, IVIG, liquid, CSL, IgPro10
公司CSL Behring
药物类别多克隆抗体, 抗体
给药途径Injectable (Others), Intravenous (IV)
状态Approved

治疗适应症

IVIG 针对 9 个适应症,涉及 6 个治疗领域。

治疗领域疾病/病症分期
Skin and subcutaneous tissue disordersPurpura✓ Approved
Immune system disordersImmunodeficiency✓ Approved
Nervous system disordersMultifocal motor neuropathy✓ Approved
Musculoskeletal and connective tissue disordersScleroderma✓ Approved
Nervous system disordersGuillain-Barre syndrome✓ Approved

注册免费账户还可查看另外 4 个适应症

免费注册查看全部适应症 →

相关研究文献

PubMedEuropean journal of pediatrics2026-11-19

KAWACALP study: the utility of serum calprotectin as a prognostic biomarker in Kawasaki disease.

Mercader Rodríguez Beatriz B, Avilés Plaza Francisco V FV, Sorlí García Moisés M, Fernández Cooke Elisa E et al.

To assess if serum calprotectin (sCP) can be used as a predictor of resistance to intravenous immunoglobulin treatment (IVIG) and coronary artery aneurysms (CAA) in Kawasaki disease (KD). A multicenter, observational, cohort study was conducted prospectively between September 2018 and February 2023. sCP was analyzed at four points in the evolution of KD in 74 patients from four Spanish hospitals. The sCP and other clinical and analytical values were compared between groups: IVIG responders or sensitive KD patients (SKD) versus IVIG nonresponders or refractory KD patients (RKD), and KD patients with CAA versus those without CAA. In refractory KD patients and in those who developed CAA, sCP was higher at the moment of diagnosis and remained elevated after treatment with IVIG, unlike what happened in sensitive KD patients and in those without CAA. A post-treatment sCP level ≥ 14.09 μg/ml predicted RKD with Sn 75% and Sp 72.97% (AUC 0.75). A pre-treatment sCP cutoff of ≥ 21.49 μg/ml predicted CAA with Sn:100% and Sp 71.05% (AUC 0.86). A post-treatment sCP value ≥ 14.76 μg/ml predicted CAA with S 71.43% and Sp 76.32% (AUC 0.74). Serum CP at the time of diagnosis ≥ 21.49 μg/ml has a sensitivity of 100% to detect CAA. Therefore, if these results are confirmed in larger studies, sCP may be used as a prognostic biomarker in patients with Kawasaki disease, to detect early patients with a higher probability of CAA occurrence, guide treatment decisions and ultimately reduce cardiac complications. • At present, no validated biomarkers allow early identification of IVIG resistance or predict coronary involvement in KD patients. • High serum calprotectin level at the diagnosis of KD and persistently elevated levels after IVIG treatment may identify patients at risk for IVIG resistance and coronary complications.

PMID 43052573
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Coexisting Liquid-, Glassy-, and Crystal-like Phonons in a Crystalline Solid.

Feng Yuanwen Y, Xie Lin L, Ohira-Kawamura Seiko S, Qi Ji J et al.

As main states of matter, crystal, glass, and liquid manifest themselves in distinct transverse collective atomic vibrations. In contrast to crystals where transverse phonons are well-defined throughout Brillouin zones, glasses and liquids process such motions in long and/or short wavelength limits, respectively. Considerable efforts have been made to experimentally probe transverse phonon behavior in these highly anharmonic and disordered materials in pursuit of a universal framework for thermal transport. In this work, inelastic neutron scattering on AgCrSe2 single crystals reveals liquid-, glassy-, and crystal-like phonon features along different crystallographic directions. In particular, the liquid-like behavior is attributed to the significant softening and scattering arising from the nesting effect and dynamical atomic disorder while the glassy-like behavior is due to the selective disorder effect. Our findings challenge conventional boundaries between states of matter at the level of atomic dynamics and establish a materials platform for unifying the thermal transport theories across different states.

PMID 43053416
阅读全文 →
PubMedLuminescence : the journal of biological and chemical luminescence2026-11-19

Molecularly Engineered Triphenylamine-Based Schiff Base Co-Sensitizers for DSSCs With Liquid and PAN/PEG Polymer Gel Electrolytes and for 12% Efficient Tandem Devices With Liquid Electrolyte.

Abumelha Hana M HM, Osra Khalid A KA, Alshahrani Maryam M, Alshammari Nadiyah M NM et al.

Two novel triphenylamine-based donor-π-acceptor Schiff base sensitizers, TBY-1 and TBC-1, were systematically designed, synthesized, and assessed as co-sensitizers with N719 for the enhancement photovoltaic performance. The two dyes were constructed to probe the effect of acceptor engineering on light harvesting, charge-transfer characteristics, and device efficiency. Spectroscopic analysis showed that TBC-1 exhibited broader and more red-shifted visible absorption than TBY-1, indicating stronger intramolecular charge transfer and improved solar-spectrum utilization. Density functional theory and complementary electronic analyses further confirmed that TBC-1 possesses enhanced electron delocalization, stronger donor-acceptor separation, and more favorable interfacial electronic characteristics. When co-sensitized with N719, both dyes significantly improved the photovoltaic performance relative to N719 alone in both liquid and PAN/PEG polymer gel electrolytes. The best liquid-electrolyte device, based on TBC-1 + N719, achieved a power conversion efficiency of 11.98% with VOC = 0.740 V, JSC = 23.50 mA cm-2, and FF = 68.89%, while the corresponding quasi-solid-state device retained a high efficiency of 10.45%. Upon using parallel tandem DSSC with the N719 (top)/TBC-1 (bottom) delivering the highest efficiency of 12.34% under AM 1.5G illumination. Electrochemical impedance and Bode analyses revealed that the improved performance originated from enhanced light harvesting, suppressed interfacial recombination, and prolonged electron lifetime, while long-term stability measurements demonstrated excellent operational durability over 300 h of continuous illumination. These findings highlight acceptor engineering and tandem sensitization as effective strategies for developing efficient and stable next-generation DSSCs.

PMID 43053595
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

An Aqueous Phase Transition Electrolyte Retaining High Ionic Conductivity after Solidification for Low-Temperature Zinc-Iodine Batteries.

Li Xixian X, Yang Qi Q, Wang Hongwei H, Xu Wenyu W et al.

Conventional low-temperature aqueous electrolytes are primarily designed to suppress electrolyte freezing and thereby preserve ion transport in the liquid state, but such strategies become ineffective once electrolyte solidification becomes unavoidable. Here, we report an aqueous phase-transition electrolyte (PTE) that preserves intimate electrode-electrolyte contact and exhibits high ionic conductivity after solidification. Systematic characterization reveals that the solidified PTE consists of an interconnected ice framework permeated by a continuous liquid electrolyte, whereas a conventional ZnSO4-based electrolyte (ZSBE) forms isolated salt domains within the ice matrix, resulting in poor interfacial contact and limited ionic transport. This unique architecture establishes continuous ion-transport pathways throughout the solidified electrolyte, enabling an ionic conductivity of 1.870 mS cm-1 at -60 °C, compared to only 0.065 mS cm-1 for ZSBE. Using an aqueous Zn||I2 battery as a model system, PTE affords exceptional cycling stability and rate capability at low temperatures, achieving a record-high cycling lifespan of 430 000 cycles at 40 A g-1 and -40 °C. An Ah-level pouch cell remains operational in liquid nitrogen, powering 107 light-emitting diodes. This work marks a paradigm shift from preventing electrolyte freezing to sustaining high ionic conductivity after solidification for low-temperature aqueous batteries.

PMID 43053386
阅读全文 →
PubMedNature communications2026-11-19

Bicontinuous Fibre Formation via Co-precipitate Attenuated Solvent Transfer Induced Assembly.

Kharal Shankar P SP, Gao Yawei Y, Bo Luyu L, Damron Joshua T JT et al.

Polymer-solvent-nonsolvent mixtures provide a versatile route for fabricating structured materials through liquid-liquid phase separation. In this context, solvent transfer-induced phase separation (STrIPS) enables the continuous formation of bicontinuous fibres, yet the process is often limited by coarsening of pores or collapse within the fibre core, leading to structural inhomogeneity. Here, we advance this strategy through Co-precipitate Attenuated Solvent Transfer induced assembly (CAST), in which amphiphilic species precipitate in situ during solvent exchange and preferentially retained within the polymer rich phase. These precipitates act as a distributed molecular retarding agent that delays domain growth, thereby preserving bicontinuity throughout the fibre cross-section to up to 250 µm. Using a poly (ethylene glycol) diacrylate-ethanol-water system with a phenolic oligomer coprecipitate, we demonstrate that CAST stabilizes the hollow bicontinuous domain structure, extending the attainable specific surface area by ca. 100%. Scattering experiments and molecular dynamics simulations confirm that the precipitating species suppress coarsening by restricting mobility within the phase they occupy. Embedding CAST fibres within polydimethylsiloxane demonstrates lightweight composites with sound mitigation capabilities, highlighting the potential for acoustic applications. CAST thus establishes a versatile route to high-performance porous materials with broad potential for structural, acoustic, and energy applications.

PMID 43052242
阅读全文 →
PubMedBiomarker research2026-11-19

Circulating biomarkers in early-stage hepatocellular carcinoma for risk stratification, diagnosis and prognosis.

Monti Elisa E, Bella Marco M, Vianello Clara C, Galvani Giuseppe G et al.

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, largely due to tumor heterogeneity, late diagnosis, and high recurrence rates even after curative treatment. Although HCC is potentially curable when detected at an early stage, suboptimal surveillance, particularly in patients with underlying cirrhosis or metabolic risk factors, limits the proportion of patients eligible for curative therapies. Current surveillance strategies for at-risk populations have intrinsic limitations, and the performance of imaging and serum biomarkers remains suboptimal. Moreover, the lack of reliable prognostic biomarkers for detecting early recurrence hampers post-treatment surveillance and impacts clinical outcomes. In this context, circulating biomarkers have emerged as promising tools for improving both early detection and prognostic stratification. Liquid biopsy has the potential to enable early, non-invasive diagnosis of HCC and allows longitudinal assessment of tumor progression through serial sampling. In early-stage HCC, blood candidates may complement or outperform conventional approaches by enabling earlier diagnosis and more accurate risk stratification. In this review, we summarize recent advances and current challenges in the clinical translation of circulating biomarkers. We focus on key liquid biopsy components, including circulating cell-free DNA, particularly circulating tumor DNA, circulating tumor cells, non-coding RNAs, extracellular vesicles, proteins and metabolites, such as bile acids and lipids, highlighting their diagnostic and prognostic potential and their possible integration into personalized management strategies for patients with early-stage HCC.

PMID 43053253
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多IVIG